Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients

Completed · Phase 1

Conditions studied: Infections, Respiratory Tract

In brief

Clinical research study to test amoxicillin and clavulanate tablet formulation for use in Acute Bacterial Sinusitis (ABS) in adolescent patients weighing at least 40 kilogram (kg) and no more than 16 years old. ABS is an acute bacterial infection of the sinus. The purpose of this study is to find out how children tolerate Augmentin XR and what happens to Augmentin XR in the body after it has been swallowed by children.

Key facts

Study ID

NCT00354965

Run by

GlaxoSmithKline

People needed

52

Starts

2006-01-19

Expected to finish

2007-04-02

Last updated by the study team

2017-08-01

Who can join

Age: any, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient weighs at least 40 kg.
• Younger than 16 years old (no older than their 16th birthday).
• Suspected acute bacterial sinusitis.
• Able to swallow amoxicillin/clavulanate tablets.

You may not qualify if…

• Personal or family history of adverse reactions or hypersensitivity or allergy to any penicillin or cephalosporin antibiotics.
• History of reaction to multiple allergens (if considered clinically relevant by the principal investigator).
• Patient is participating in another clinical trial or has received or anticipates receiving an investigational drug, vaccine, or medical device prior to the first dose of study medication or during the conduct of the study.
• History or presence of gastrointestinal, hepatic or renal disease or other conditions known to or that may interfere with the absorption, distribution, metabolism or excretion of study medication.
• Treatment with probenecid or allopurinol within 7 days of study entry.
• Female patients with a positive urine hCG (human chorionic gonadotropin) test at screening, or who are lactating (breast feeding) or are unwilling to be abstinent until completion of the follow-up visit.
• History of diarrhea due to Clostridium difficile following treatment with antibiotics.
• History of hypersensitivity or allergy to heparin or related preparations (if the clinical research unit uses heparin to maintain intravenous cannula patency).
• Patient is diagnosed with mononucleosis.
• Estimated Glomerular Filtration Rate (GFR) <40 ml/min.

Where it is running

• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — North Dartmouth, Massachusetts, United States
• GSK Investigational Site — Sylva, North Carolina, United States
• GSK Investigational Site — Cleveland, Ohio, United States
• GSK Investigational Site — Erie, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.